Milsaperidone: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Milsaperidone. Educational only — not medical advice.
Labeled uses
BYSANTI™ is indicated for the: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ] . Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] .
Source: FDA labeling via NIH DailyMed (set 254a1c01…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.